Human ex vivo models of interstitial lung disease
Symposium Chairs: R. Gosens (Groningen, Netherlands), M. Proesmans (Leuven, Belgium)
Aims: To present models of early events of idiopathic pulmonary fibrosis (IPF) ex vivo and the use of these models in evaluating pathogenesis and treatment; and to evaluate the potential use of lung organoids for drug screening.